The effects of ghrelin on inflammation and the immune system

Molecular and Cellular Endocrinology

Volumn 340, Issue 1, 2011, Pages 44-58

  Baatar, Dolgor ^a   Patel, Kalpesh ^a   Taub, Dennis D ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Aging; Ghrelin; GHS R; IL 6; Inflammation; Proinflammatory cytokines; Sepsis; Thymus

Indexed keywords

GHRELIN; GHRELIN RECEPTOR; GROWTH HORMONE SECRETAGOGUE; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; BRAIN INJURY; BRAIN ISCHEMIA; CACHEXIA; CARDIOVASCULAR DISEASE; CELL MATURATION; CHRONIC KIDNEY DISEASE; COLITIS; DRUG EFFICACY; DRUG SAFETY; ENDOTOXEMIA; EVENING DOSAGE; FOOD INTAKE; GASTROINTESTINAL DISEASE; HEART MUSCLE ISCHEMIA; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE SYNTHESIS; HUMAN; HYPERALGESIA; IMMUNE SYSTEM; IMMUNOREGULATION; INFLAMMATION; INFLAMMATORY DISEASE; ISCHEMIA; KIDNEY FAILURE; LIVER INJURY; METABOLISM; MORNING DOSAGE; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; PAIN; PANCREAS DUCT STENOSIS; PANCREATITIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REPERFUSION INJURY; RESPIRATORY TRACT INFECTION; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; THYMUS; TRAUMATIC BRAIN INJURY;

ANIMALS; GHRELIN; HUMANS; IMMUNE SYSTEM; INFLAMMATION; LYMPHOCYTES; RECEPTORS, GHRELIN; T-LYMPHOCYTES;

EID: 79958082780     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.04.019     Document Type: Review

References (116)

1. Ashitani J., Matsumoto N., Nakazato M. Ghrelin and its therapeutic potential for cachectic patients. Peptides 2009, 30:1951-1956.
2. Balasubramaniam A., Joshi R., Su C., Friend L.A., Sheriff S., Kagan R.J., James J.H. Ghrelin inhibits skeletal muscle protein breakdown in rats with thermal injury through normalizing elevated expression of E3 ubiquitin ligases MuRF1 and MAFbx. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 296:R893-R901.
3. Baldanzi G., Filigheddu N., Cutrupi S., Catapano F., Bonissoni S., Fubini A., Malan D., Baj G., Granata R., Broglio F., et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J. Cell Biol. 2002, 159:1029-1037.
4. Bansal V., Ryu S.Y., Blow C., Costantini T., Loomis W., Eliceiri B., Baird A., Wolf P., Coimbra R. The hormone ghrelin prevents traumatic brain injury induced intestinal dysfunction. J. Neurotrauma 2010, 27:2255-2260.
5. Barnard A., Layton D., Hince M., Sakkal S., Bernard C., Chidgey A., Boyd R. Impact of the neuroendocrine system on thymus and bone marrow function. Neuroimmunomodulation 2008, 15:7-18.
6. Basa N.R., Wang L., Arteaga J.R., Heber D., Livingston E.H., Tache Y. Bacterial lipopolysaccharide shifts fasted plasma ghrelin to postprandial levels in rats. Neurosci. Lett. 2003, 343:25-28.
7. Bauer J.M., Haack A., Winning K., Wirth R., Fischer B., Uter W., Erdmann J., Schusdziarra V., Sieber C.C. Impaired postprandial response of active ghrelin and prolonged suppression of hunger sensation in the elderly. J. Gerontol. A: Biol. Sci. Med. Sci. 2010, 65:307-311.
8. Bernotiene E., Palmer G., Gabay C. The role of leptin in innate and adaptive immune responses. Arthritis Res. Ther. 2006, 8:217.
9. Bowers C.Y. Unnatural growth hormone-releasing peptide begets natural ghrelin. J. Clin. Endocrinol. Metab. 2001, 86:1464-1469.
10. Cai B., Deitch E.A., Ulloa L. Novel insights for systemic inflammation in sepsis and hemorrhage. Mediat. Inflamm. 2010, 642:462.
11. Camina J.P., Lodeiro M., Ischenko O., Martini A.C., Casanueva F.F. Stimulation by ghrelin of p42/p44 mitogen-activated protein kinase through the GHS-R1a receptor: role of G proteins and beta-arrestins. J. Cell Physiol. 2007, 213:187-200.
12. Chang L., Zhao J., Yang J., Zhang Z., Du J., Tang C. Therapeutic effects of ghrelin on endotoxic shock in rats. Eur. J. Pharmacol. 2003, 473:171-176.
13. Chang L., Ren Y., Liu X., Li W.G., Yang J., Geng B., Weintraub N.L., Tang C. Protective effects of ghrelin on ischemia/reperfusion injury in the isolated rat heart. J. Cardiovasc. Pharmacol. 2004, 43:165-170.
14. Chen J., Liu X., Shu Q., Li S., Luo F. Ghrelin attenuates lipopolysaccharide-induced acute lung injury through NO pathway. Med. Sci. Monit. 2008, 14:BR141-BR146.
15. Cheyuo C., Wu R., Zhou M., Jacob A., Coppa G., Wang P. Ghrelin suppresses inflammation and neuronal nitric oxide synthase in focal cerebral ischemia via the vagus nerve. Shock 2010, 35:258-265.
16. Chorny A., Anderson P., Gonzalez-Rey E., Delgado M. Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria. J. Immunol. 2008, 180:8369-8377.
17. Chung H., Seo S., Moon M., Park S. Phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3 beta and ERK1/2 pathways mediate protective effects of acylated and unacylated ghrelin against oxygen-glucose deprivation-induced apoptosis in primary rat cortical neuronal cells. J. Endocrinol. 2008, 198(3):511-521.
18. De Smet B., Thijs T., Moechars D., Colsoul B., Polders L., VerDonck L., Coulie B., Peeters T.L., Depoortere I. Endogenous and exogenous ghrelin enhance the colonic and gastric manifestations of dextran sodium sulphate-induced colitis in mice. Neurogastroenterol. Motil. 2009, 21:59-70.
19. De Winter B.Y., De Man J.G., Seerden T.C., Depoortere I., Herman A.G., Peeters T.L., Pelckmans P.A. Effect of ghrelin and growth hormone-releasing peptide 6 on septic ileus in mice. Neurogastroenterol. Motil. 2004, 16:439-446.
20. Deboer M.D., Zhu X., Levasseur P.R., Inui A., Hu Z., Han G., Mitch W.E., Taylor J.E., Halem H.A., Dong J.Z., et al. Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile. Endocrinology 2008, 149:827-835.
21. Dembinski A., Warzecha Z., Ceranowicz P., Tomaszewska R., Stachura J., Konturek S.J., Konturek P.C. Ghrelin attenuates the development of acute pancreatitis in rat. J. Physiol. Pharmacol. 2003, 54:561-573.
22. Dezaki K., Kakei M., Yada T. Ghrelin uses Galphai2 and activates voltage-dependent K+ channels to attenuate glucose-induced Ca2+ signaling and insulin release in islet beta-cells: novel signal transduction of ghrelin. Diabetes 2007, 56(9):2319-2327.
23. Dimitrova D.Z., Dimitrov S.D., Iliev I., Mladenov M.I., Hristov K.L., Mihov D.N., Duridanova D.B., Gagov H.S. Ghrelin signaling in human mesenteric arteries. J. Physiol. Pharmacol. 2010, 61(4):383-390.
24. Dixit V.D. Adipose-immune interactions during obesity and caloric restriction: reciprocal mechanisms regulating immunity and health span. J. Leukoc. Biol. 2008, 84:882-892.
25. Dixit V.D., Schaffer E.M., Pyle R.S., Collins G.D., Sakthivel S.K., Palaniappan R., Lillard J.W., Taub D.D. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J. Clin. Invest. 2004, 114:57-66.
26. Dixit V.D., Taub D.D. Ghrelin and immunity: a young player in an old field. Exp. Gerontol. 2005, 40:900-910.
27. Dixit V.D., Weeraratna A.T., Yang H., Bertak D., Cooper-Jenkins A., Riggins G.J., Eberhart C.G., Taub D.D. Ghrelin and the growth hormone secretagogue receptor constitute a novel autocrine pathway in astrocytoma motility. J. Biol. Chem. 2006, 281:16681-16690.
28. Dixit V.D., Yang H., Cooper-Jenkins A., Giri B.B., Patel K., Taub D.D. Reduction of T cell-derived ghrelin enhances proinflammatory cytokine expression: implications for age-associated increases in inflammation. Blood 2009, 113:5202-5205.
29. Dixit V.D., Yang H., Sun Y., Weeraratna A.T., Youm Y.H., Smith R.G., Taub D.D. Ghrelin promotes thymopoiesis during aging. J. Clin. Invest. 2007, 117:2778-2790.
30. Dorshkind K., Horseman N.D. The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: insights from genetic models of hormone and hormone receptor deficiency. Endocr. Rev. 2000, 21:292-312.
31. Endo M., Masaki T., Seike M., Yoshimatsu H. Involvement of stomach ghrelin and hypothalamic neuropeptides in tumor necrosis factor-alpha-induced hypophagia in mice. Regul. Pept. 2007, 140:94-100.
32. Ersahin M., Toklu H.Z., Erzik C., Cetinel S., Akakin D., Velioglu-Ogunc A., Tetik S., Ozdemir Z.N., Sener G., Yegen B.C. The anti-inflammatory and neuroprotective effects of ghrelin in subarachnoid hemorrhage-induced oxidative brain damage in rats. J. Neurotrauma 2010, 27:1143-1155.
33. Frutos M.G., Cacicedo L., Fernandez C., Vicent D., Velasco B., Zapatero H., Sanchez-Franco F. Insights into a role of GH secretagogues in reversing the age-related decline in the GH/IGF-I axis. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E1140-E1152.
34. Fulop T., Larbi A., Wikby A., Mocchegiani E., Hirokawa K., Pawelec G. Dysregulation of T-cell function in the elderly: scientific basis and clinical implications. Drugs Aging 2005, 22:589-603.
35. Gnanapavan S., Kola B., Bustin S.A., Morris D.G., McGee P., Fairclough P., Bhattacharya S., Carpenter R., Grossman A.B., Korbonits M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J. Clin. Endocrinol. Metab. 2002, 87:2988.
36. Golestan Jahromi M., Nabavizadeh F., Vahedian J., Nahrevanian H., Dehpour A.R., Zare-Mehrjardi A. Protective effect of ghrelin on acetaminophen-induced liver injury in rat. Peptides 2010, 31:2114-2117.
37. Gonzalez-Rey E., Chorny A., Delgado M. Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology 2006, 130:1707-1720.
38. Gonzalez-Rey E., Ganea D., Delgado M. Neuropeptides: keeping the balance between pathogen immunity and immune tolerance. Curr. Opin. Pharmacol. 2010, 10:473-481.
39. Granado M., Priego T., Martin A.I., Villanua M.A., Lopez-Calderon A. Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E486-E492.
40. Granado M., Priego T., Martin A.I., Villanua M.A., Lopez-Calderon A. Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2005, 289:E1007-E1014.
41. Granata R., Settanni F., Biancone L., Trovato L., Nano R., Bertuzzi F., Destefanis S., Annunziata M., Martinetti M., Catapano F., et al. Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3',5'-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-kinase/Akt signaling. Endocrinology 2007, 148:512-529.
42. Guneli E., Onal A., Ates M., Bagriyanik H.A., Resmi H., Orhan C.E., Kolatan H.E., Gumustekin M. Effects of repeated administered ghrelin on chronic constriction injury of the sciatic nerve in rats. Neurosci. Lett. 2010, 479:226-230.
43. Hataya Y., Akamizu T., Hosoda H., Kanamoto N., Moriyama K., Kangawa K., Takaya K., Nakao K. Alterations of plasma ghrelin levels in rats with lipopolysaccharide-induced wasting syndrome and effects of ghrelin treatment on the syndrome. Endocrinology 2003, 144:5365-5371.
44. Hattori N. Expression, regulation and biological actions of growth hormone (GH) and ghrelin in the immune system. Growth Horm. IGF Res. 2009, 19:187-197.
45. Hattori N., Saito T., Yagyu T., Jiang B.H., Kitagawa K., Inagaki C. GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. J. Clin. Endocrinol. Metab. 2001, 86:4284-4291.
46. Howard A.D., Feighner S.D., Cully D.F., Arena J.P., Liberator P.A., Rosenblum C.I., Hamelin M., Hreniuk D.L., Palyha O.C., Anderson J., et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996, 273:974-977.
47. Huang C.X., Yuan M.J., Huang H., Wu G., Liu Y., Yu S.B., Li H.T., Wang T. Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect. Peptides 2009, 30:2286-2291.
48. Iseri S.O., Sener G., Saglam B., Ercan F., Gedik N., Yegen B.C. Ghrelin alleviates biliary obstruction-induced chronic hepatic injury in rats. Regul. Pept. 2008, 146:73-79.
49. Isomoto H., Nakazato M., Ueno H., Date Y., Nishi Y., Mukae H., Mizuta Y., Ohtsuru A., Yamashita S., Kohno S. Low plasma ghrelin levels in patients with Helicobacter pylori-associated gastritis. Am. J. Med. 2004, 117:429-432.
50. Jacob A., Rajan D., Pathickal B., Balouch I., Hartman A., Wu R., Zhou M., Wang P. The inhibitory effect of ghrelin on sepsis-induced inflammation is mediated by the MAPK phosphatase-1. Int. J. Mol. Med. 2010, 25:159-164.
51. Jeffery P.L., Herington A.C., Chopin L.K. The potential autocrine/paracrine roles of ghrelin and its receptor in hormone-dependent cancer. Cytokine Growth Factor Rev. 2003, 14:113-122.
52. Kasimay O., Iseri S.O., Barlas A., Bangir D., Yegen C., Arbak S., Yegen B.C. Ghrelin ameliorates pancreaticobiliary inflammation and associated remote organ injury in rats. Hepatol. Res. 2006, 36:11-19.
53. Katergari S.A., Milousis A., Pagonopoulou O., Asimakopoulos B., Nikolettos N.K. Ghrelin in pathological conditions. Endocr. J. 2008, 55:439-453.
54. Kelley K.W., Bluthe R.M., Dantzer R., Zhou J.H., Shen W.H., Johnson R.W., Broussard S.R. Cytokine-induced sickness behavior. Brain Behav. Immun. 2003, 17(Suppl. 1):S112-S118.
55. Kellokoski E., Kunnari A., Jokela M., Makela S., Kesaniemi Y.A., Horkko S. Ghrelin and obestatin modulate early atherogenic processes on cells: enhancement of monocyte adhesion and oxidized low-density lipoprotein binding. Metabolism 2009, 58:1572-1580.
56. Kerem M., Bedirli A., Pasaoglu H., Unsal C., Yilmaz T.U., Ofluoglu E., Sahin T.T. Role of ghrelin and leptin in predicting the severity of acute pancreatitis. Dig. Dis. Sci. 2007, 52:950-955.
57. Kodama T., Ashitani J., Matsumoto N., Kangawa K., Nakazato M. Ghrelin treatment suppresses neutrophil-dominant inflammation in airways of patients with chronic respiratory infection. Pulm. Pharmacol. Ther. 2008, 21:774-779.
58. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
59. Kojima M., Kangawa K. Ghrelin: structure and function. Physiol. Rev. 2005, 85:495-522.
60. Koo G.C., Huang C., Camacho R., Trainor C., Blake J.T., Sirotina-Meisher A., Schleim K.D., Wu T.J., Cheng K., Nargund R., et al. Immune enhancing effect of a growth hormone secretagogue. J. Immunol. 2001, 166:4195-4201.
61. Laviano A., Krznaric Z., Sanchez-Lara K., Preziosa I., Cascino A., Rossi Fanelli F. Chronic renal failure, cachexia, and ghrelin. Int. J. Pept. 2010, 2010:1-5. Article ID 648045.
62. Li W.G., Gavrila D., Liu X., Wang L., Gunnlaugsson S., Stoll L.L., McCormick M.L., Sigmund C.D., Tang C., Weintraub N.L. Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells. Circulation 2004, 109:2221-2226.
63. Malagón M.M., Luque R.M., Ruiz-Guerrero E., Rodríguez-Pacheco F., García-Navarro S., Casanueva F.F., Gracia-Navarro F., Castaño J.P. Intracellular signaling mechanisms mediating ghrelin-stimulated growth hormone release in somatotropes. Endocrinology 2003, 144(12):5372-5380.
64. Maruna P., Gurlich R., Frasko R., Rosicka M. Ghrelin and leptin elevation in postoperative intra-abdominal sepsis. Eur. Surg. Res. 2005, 37:354-359.
65. Mousseaux D., Le Gallic L., Ryan J., Oiry C., Gagne D., Fehrentz J.A., Galleyrand J.C., Martinez J. Regulation of ERK1/2 activity by ghrelin-activated growth hormone secretagogue receptor 1A involves a PLC/PKCepsilon pathway. Br. J. Pharmacol. 2006, 148(3):350-365.
66. Nagaya N., Itoh T., Murakami S., Oya H., Uematsu M., Miyatake K., Kangawa K. Treatment of cachexia with ghrelin in patients with COPD. Chest 2005, 128:1187-1193.
67. Nagaya N., Kangawa K. Ghrelin improves left ventricular dysfunction and cardiac cachexia in heart failure. Curr. Opin. Pharmacol. 2003, 3:146-151.
68. Nagaya N., Miyatake K., Uematsu M., Oya H., Shimizu W., Hosoda H., Kojima M., Nakanishi N., Mori H., Kangawa K. Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure. J. Clin. Endocrinol. Metab. 2001, 86:5854-5859.
69. Nagaya N., Uematsu M., Kojima M., Ikeda Y., Yoshihara F., Shimizu W., Hosoda H., Hirota Y., Ishida H., Mori H., et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 2001, 104:1430-1435.
70. O'Connor J.C., McCusker R.H., Strle K., Johnson R.W., Dantzer R., Kelley K.W. Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology. Cell. Immunol. 2008, 252:91-110.
71. Osawa H., Nakazato M., Date Y., Kita H., Ohnishi H., Ueno H., Shiiya T., Satoh K., Ishino Y., Sugano K. Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. J. Clin. Endocrinol. Metab. 2005, 90:10-16.
72. Otero M., Nogueiras R., Lago F., Dieguez C., Gomez-Reino J.J., Gualillo O. Chronic inflammation modulates ghrelin levels in humans and rats. Rheumatology (Oxford) 2004, 43:306-310.
73. Patel K., Taub D.D. Role of neuropeptides, hormones, and growth factors in regulating thymopoiesis in middle to old age. F1000 Biol. Rep. 2009, 1:42. 10.3410/B1-42.
74. Poli-de-Figueiredo L.F., Garrido A.G., Nakagawa N., Sannomiya P. Experimental models of sepsis and their clinical relevance. Shock 2008, 30(Suppl. 1):53-59.
75. Redelman D., Welniak L.A., Taub D., Murphy W.J. Neuroendocrine hormones such as growth hormone and prolactin are integral members of the immunological cytokine network. Cell. Immunol. 2008, 252:111-121.
76. Rossi F., Castelli A., Bianco M.J., Bertone C., Brama M., Santiemma V. Ghrelin induces proliferation in human aortic endothelial cells via ERK1/2 and PI3K/Akt activation. Peptides 2008, 29(11):2046-2051.
77. Savino W. Neuroendocrine control of T cell development in mammals: role of growth hormone in modulating thymocyte migration. Exp. Physiol. 2007, 92:813-817.
78. Serra-Prat M., Alfaro S.R., Palomera E., Casamitjana R., Buquet X., Fernandez-Fernandez C., Puig-Domingo M. Relationship between ghrelin and the metabolic syndrome in the elderly: a longitudinal population-based study. Clin. Endocrinol. (Oxf.) 2009, 70:227-232.
79. Serra-Prat M., Palomera E., Roca M., Puig-Domingo M. Long-term effect of ghrelin on nutritional status and functional capacity in the elderly: a population-based cohort study. Clin. Endocrinol. (Oxf.) 2010, 73:41-47.
80. Shah K.G., Wu R., Jacob A., Blau S.A., Ji Y., Dong W., Marini C.P., Ravikumar T.S., Coppa G.F., Wang P. Human ghrelin ameliorates organ injury and improves survival after radiation injury combined with severe sepsis. Mol. Med. 2009, 15:407-414.
81. Sibilia V., Lattuada N., Rapetti D., Pagani F., Vincenza D., Bulgarelli I., Locatelli V., Guidobono F., Netti C. Ghrelin inhibits inflammatory pain in rats: involvement of the opioid system. Neuropharmacology 2006, 51:497-505.
82. Smith R.G., Jiang H., Sun Y. Developments in ghrelin biology and potential clinical relevance. Trends Endocrinol. Metab. 2005, 16:436-442.
83. Smith R.G., Leonard R., Bailey A.R., Palyha O., Feighner S., Tan C., McKee K.K., Pong S.S., Griffin P., Howard A. Growth hormone secretagogue receptor family members and ligands. Endocrine 2001, 14:9-14.
84. Steinman L. Elaborate interactions between the immune and nervous systems. Nat. Immunol. 2004, 5:575-581.
85. Sun Y., Ahmed S., Smith R.G. Deletion of ghrelin impairs neither growth nor appetite. Mol. Cell Biol. 2003, 23:7973-7981.
86. Sun Y., Butte N.F., Garcia J.M., Smith R.G. Characterization of adult ghrelin and ghrelin receptor knockout mice under positive and negative energy balance. Endocrinology 2008, 149:843-850.
87. Sun Y., Wang P., Zheng H., Smith R.G. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:4679-4684.
88. Suzuki H., Masaoka T., Nomoto Y., Hosoda H., Mori M., Nishizawa T., Minegishi Y., Kangawa K., Hibi T. Increased levels of plasma ghrelin in peptic ulcer disease. Aliment Pharmacol. Ther. 2006, 4:120-126.
89. Taub D.D. Novel connections between the neuroendocrine and immune systems: the ghrelin immunoregulatory network. Vitam. Horm. 2007, 77:325-346.
90. Taub D.D. Neuroendocrine interactions in the immune system. Cell. Immunol. 2008, 252:1-6.
91. Taub D.D., Longo D.L. Insights into thymic aging and regeneration. Immunol. Rev. 2005, 205:72-93.
92. Taub D.D., Murphy W.J., Longo D.L. Rejuvenation of the aging thymus: growth hormone-mediated and ghrelin-mediated signaling pathways. Curr. Opin. Pharmacol. 2010, 10:408-424.
93. Theil M.M., Miyake S., Mizuno M., Tomi C., Croxford J.L., Hosoda H., Theil J., von Horsten S., Yokote H., Chiba A., et al. Suppression of experimental autoimmune encephalomyelitis by ghrelin. J. Immunol. 2009, 183:2859-2866.
94. Toussirot E., Streit G., Nguyen N.U., Dumoulin G., Le Huede G., Saas P., Wendling D. Adipose tissue, serum adipokines, and ghrelin in patients with ankylosing spondylitis. Metabolism 2007, 56:1383-1389.
95. van der Lely A.J., Tschop M., Heiman M.L., Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr. Rev. 2004, 25:426-457.
96. Vila G., Maier C., Riedl M., Nowotny P., Ludvik B., Luger A., Clodi M. Bacterial endotoxin induces biphasic changes in plasma ghrelin in healthy humans. J. Clin. Endocrinol. Metab. 2007, 92:3930-3934.
97. Wang L., Basa N.R., Shaikh A., Luckey A., Heber D., St-Pierre D.H., Tache Y. LPS inhibits fasted plasma ghrelin levels in rats: role of IL-1 and PGs and functional implications. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 291:G611-G620.
98. Wang W., Bansal S., Falk S., Ljubanovic D., Schrier R. Ghrelin protects mice against endotoxemia-induced acute kidney injury. Am. J. Physiol. Renal Physiol. 2009, 297:F1032-F1037.
99. Waseem T., Duxbury M., Ito H., Ashley S.W., Robinson M.K. Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways. Surgery 2008, 143:334-342.
100. Webster Marketon J.I., Glaser R. Stress hormones and immune function. Cell. Immunol. 2008, 252:16-26.
101. Welniak L.A., Sun R., Murphy W.J. The role of growth hormone in T-cell development and reconstitution. J. Leukoc. Biol. 2002, 71:381-387.
102. Wu R., Dong W., Cui X., Zhou M., Simms H.H., Ravikumar T.S., Wang P. Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve. Ann. Surg. 2007, 245:480-486.
103. Wu R., Dong W., Zhou M., Zhang F., Marini C.P., Ravikumar T.S., Wang P. Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats. Am. J. Respir. Crit. Care Med. 2007, 176:805-813.
104. Wu R., Zhou M., Das P., Dong W., Ji Y., Yang D., Miksa M., Zhang F., Ravikumar T.S., Wang P. Ghrelin inhibits sympathetic nervous activity in sepsis. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E1697-E1702.
105. Wu R., Dong W., Ji Y., Zhou M., Marini C.P., Ravikumar T.S., Wang P. Orexigenic hormone ghrelin attenuates local and remote organ injury after intestinal ischemia-reperfusion. PLoS ONE 2008, 3:e2026.
106. Wu R., Dong W., Zhou M., Cui X., Hank Simms H., Wang P. Ghrelin improves tissue perfusion in severe sepsis via downregulation of endothelin-1. Cardiovasc. Res. 2005, 68:318-326.
107. Wu R., Zhou M., Cui X., Simms H.H., Wang P. Ghrelin clearance is reduced at the late stage of polymicrobial sepsis. Int. J. Mol. Med. 2003, 12:777-781.
108. Wu R., Zhou M., Cui X., Simms H.H., Wang P. Upregulation of cardiovascular ghrelin receptor occurs in the hyperdynamic phase of sepsis. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H1296-H1302.
109. Xia Q., Pang W., Pan H., Zheng Y., Kang J.S., Zhu S.G. Effects of ghrelin on the proliferation and secretion of splenic T lymphocytes in mice. Regul. Pept. 2004, 122:173-178.
110. Yang H., Dixit V.D., Patel K., Vandanmagsar B., Collins G., Sun Y., Smith R.G., Taub D.D. Reduction in hypophyseal growth hormone and prolactin expression due to deficiency in ghrelin receptor signaling is associated with Pit-1 suppression: relevance to the immune system. Brain Behav. Immun. 2008, 22:1138-1145.
111. Yang J., Brown M.S., Liang G., Grishin N.V., Goldstein J.L. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 2008, 132(3):387-396.
112. Yang H., Youm Y.H., Dixit V.D. Inhibition of thymic adipogenesis by caloric restriction is coupled with reduction in age-related thymic involution. J. Immunol. 2009, 183:3040-3052.
113. Youm Y.H., Yang H., Sun Y., Smith R.G., Manley N.R., Vandanmagsar B., Dixit V.D. Deficient ghrelin receptor-mediated signaling compromises thymic stromal cell microenvironment by accelerating thymic adiposity. J. Biol. Chem. 2009, 284:7068-7077.
114. Yuan M.J., Huang C.X., Tang Y.H., Wang X., Huang H., Chen Y.J., Wang T. A novel peptide ghrelin inhibits neural remodeling after myocardial infarction in rats. Eur. J. Pharmacol. 2009, 618:52-57.
115. Zhou X., Xue C. Ghrelin inhibits the development of acute pancreatitis and nuclear factor kappaB activation in pancreas and liver. Pancreas 2009, 38:752-757.
116. Zigman J.M., Nakano Y., Coppari R., Balthasar N., Marcus J.N., Lee C.E., Jones J.E., Deysher A.E., Waxman A.R., White R.D., et al. Mice lacking ghrelin receptors resist the development of diet-induced obesity. J. Clin. Invest. 2005, 115:3564-3572.